Laparoscopic ovarian drilling before IVF/ICSI in polycystic ovarian syndrome patients with high antimullarian hormone

J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102324. doi: 10.1016/j.jogoh.2022.102324. Epub 2022 Jan 19.

Abstract

Objective: To evaluate the effect of performing laparoscopic ovarian drilling [LOD] before proceeding to in vitro fertilization [IVF] or intracytoplasmic sperm injection [ICSI] on the cycle outcomes in polycystic ovarian syndrome [PCOS] patients with high antimullerian hormone [AMH] levels.

Study design: A retrospective case-control study.

Patients and methods: The study was conducted in the Fertility Care Unit in our University Hospital. The participants of the study were PCOS women with high serum AMH levels [≥ 7 ng/ml] who were subjected to IVF/ICSI. Women who underwent LOD in the preceding 3 months before IVF/ICSI [study group; n = 76] were compared with a control group of women who did not undergo LOD [control group; n = 71].

Results: Total gonadotropin consumption and the number of stimulation days were significantly lower with LOD [P = 0.026 and 0.010, respectively]. Oocyte maturity rate was significantly higher with LOD [P = 0.028]. The incidence of severe OHSS was significantly lower with LOD [P = 0.026]. No significant difference between both groups in the pregnancy and implantation rates.

Conclusion: The LOD before IVF/ICSI in PCOS patients with high AMH [≥ 7 ng/ml] has the benefits of reduction in gonadotropins consumption and stimulation days with an increase in the percentage of collected mature oocytes and decrease in the incidence of severe OHSS; however, it seems not to improve the pregnancy and implantation rates.

Keywords: AMH; LOD; OHSS; PCOS.

MeSH terms

  • Anti-Mullerian Hormone
  • Case-Control Studies
  • Female
  • Fertilization in Vitro
  • Humans
  • Laparoscopy*
  • Ovarian Hyperstimulation Syndrome* / epidemiology
  • Polycystic Ovary Syndrome* / complications
  • Pregnancy
  • Pregnancy Rate
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic

Substances

  • Anti-Mullerian Hormone